Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A practical, comprehensive classification for pediatric myelodysplastic syndromes: the CCC system.

Karen Mandel1, Yigal Dror, Annette Poon

  • 1Divison of Hematology/Oncology, Hospital for Sick Children, Department of Pediatrics, University of Toronto, Canada.

Journal of Pediatric Hematology/Oncology
|October 9, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Outcomes of Dyskeratosis Congenita: Results From the Canadian Inherited Marrow Failure Registry.

Journal of pediatric hematology/oncology·2026
Same author

A Survey of Provider Practices for Diagnosis and Treatment of Pediatric Moderate Aplastic Anemia From the North American Pediatric Aplastic Anemia Consortium.

Journal of pediatric hematology/oncology·2026
Same author

Immunosuppressive therapy for severe aplastic anemia in children under the age of 3 years yields a high response rate: a North American collaborative study.

Haematologica·2026
Same author

Steroid Responsiveness and Clinical Outcomes in Diamond-Blackfan Anemia: Analysis From the Canadian Inherited Marrow Failure Registry.

European journal of haematology·2026
Same author

Expanding genetic landscape of inherited bone marrow failure syndromes: Insights from the Canadian Inherited Marrow Failure Registry (CIMFR) (2001-2023).

British journal of haematology·2026
Same author

Passenger Lymphocyte Syndrome in Pediatric Lung Transplantation: A Recipient With Previous Hematopoietic Stem Cell Transplantation.

Pediatric transplantation·2026
Same journal

Assessment of Immunization Status Following Non-HSCT Chemotherapy-treated Pediatric Leukemia Survivors.

Journal of pediatric hematology/oncology·2026
Same journal

Frequent Use of Hematologic Testing in Children Admitted for Nonaccidental Trauma.

Journal of pediatric hematology/oncology·2026
Same journal

Unresponsive Systemic Mastocytosis in a Young AML With RUNX1::RUNX1T1 Fusion With Rare KIT c.1255_1257delGAC Mutation: A Clinical Deadlock.

Journal of pediatric hematology/oncology·2026
Same journal

Local Control and Survival Outcomes in Pediatric Nonrhabdomyosarcoma Soft Tissue Sarcoma: The Mayo Clinic Experience.

Journal of pediatric hematology/oncology·2026
Same journal

Diagnostic Pitfalls in Pediatric Acute Promyelocytic Leukemia: All-trans Retinoic Acid-Associated Hypercalcemia Mimicking Fungal Meningitis and the Risks of Azole Coadministration.

Journal of pediatric hematology/oncology·2026
Same journal

Unmanipulated Haploidentical Stem Cell Transplantation Outcome in a Pediatric Patient With CD27 Deficiency and EBV-Induced Diffuse Large B-Cell Lymphoma With Primary CNS Involvement.

Journal of pediatric hematology/oncology·2026
See all related articles

A new classification system for pediatric myelodysplastic syndromes (MDS) effectively categorizes children, overcoming limitations of adult classifications. This practical approach aids in understanding disease progression and prognosis in childhood MDS.

Area of Science:

  • Hematology
  • Pediatric Oncology
  • Clinical Classification Systems

Background:

  • Pediatric myelodysplastic syndromes (MDS) exhibit significant biological diversity.
  • Existing adult classification systems, such as the French-American-British (FAB) system, are often inadequate for classifying childhood MDS.
  • A need exists for a practical and applicable classification system tailored to pediatric MDS.

Purpose of the Study:

  • To develop and test a practical classification system for childhood MDS.
  • To address the limitations of existing classification schemas in pediatric patients.
  • To establish a uniform system for clinical practice and reporting of childhood MDS.

Main Methods:

  • Analysis of 40 children diagnosed with MDS between 1988 and 1998.

Related Experiment Videos

  • Classification based on three key features: category, cytology, and cytogenetics.
  • Exclusion of specific conditions like juvenile myelomonocytic leukemia and chronic myelomonocytic leukemia due to their distinct pathogenesis or rarity in children.

    • Main Results:

    • The developed classification system successfully categorized all 40 pediatric MDS patients.
    • Approximately 50% of patients could not be classified using the FAB system.
    • The system allowed for longitudinal classification, enabling the tracking of disease progression.

    Conclusions:

    • The new classification system demonstrates prognostic potential, with advanced classifications and cytogenetic abnormalities correlating with poorer outcomes.
    • The authors advocate for the international adoption of this system for standardized clinical practice and reporting.
    • This system offers a more accurate and comprehensive approach to understanding and managing pediatric MDS.